Cargando…

NPM1 is a Novel Therapeutic Target and Prognostic Biomarker for Ewing Sarcoma

Ewing sarcoma (ES) is a cancer that may originate from stem mesenchymal or neural crest cells and is highly prevalent in children and adolescents. In recent years, targeted therapies against immune-related genes have shown good efficacy in a variety of cancers. However, effective targets for immunot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yangfan, Fang, Yuan, Zhou, Junjie, Liu, Yulian, Wu, Shusheng, Xu, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662625/ https://www.ncbi.nlm.nih.gov/pubmed/34899858 http://dx.doi.org/10.3389/fgene.2021.771253

Ejemplares similares

Prognostic Immune-Related Genes of Patients With Ewing’s Sarcoma
por: Zhou, Yangfan, et al.
Publicado: (2021)

A Novel Defined Hypoxia-Related Gene Signature for Prognostic Prediction of Patients With Ewing Sarcoma
por: Jiang, Runyi, et al.
Publicado: (2022)

Novel Targeted Therapeutic Strategies for Ewing Sarcoma
por: Fayzullina, Daria, et al.
Publicado: (2022)

Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma
por: Ohmura, Shunya, et al.
Publicado: (2021)

Expression of lactate-related signatures correlates with immunosuppressive microenvironment and prognostic prediction in ewing sarcoma
por: Zhang, Zhao, et al.
Publicado: (2022)

CCT6A, a novel prognostic biomarker for Ewing sarcoma
por: Jiang, Jie, et al.
Publicado: (2021)

The clinical use of biomarkers as prognostic factors in Ewing sarcoma
por: van Maldegem, Annmeik M, et al.
Publicado: (2012)

Identification and validation of novel prognostic biomarkers and therapeutic targets for non-small cell lung cancer
por: Lai, Li-Ting, et al.
Publicado: (2023)

Characterizing the prognostic and therapeutic value of necroptosis in sarcoma based on necroptosis subtypes
por: Ma, Yibo, et al.
Publicado: (2022)

REV1: A novel biomarker and potential therapeutic target for various cancers
por: Zhu, Ning, et al.
Publicado: (2022)

Clinical implications of six inflammatory biomarkers as prognostic indicators in Ewing sarcoma
por: Li, Yong-Jiang, et al.
Publicado: (2017)

Novel prognostic biomarkers, METTL14 and YTHDF2, associated with RNA methylation in Ewing’s sarcoma
por: Jiang, Jie, et al.
Publicado: (2022)

Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma
por: Evola, Francesco R., et al.
Publicado: (2017)

Targeted Therapy in Ewing Sarcoma
por: Lissat, A., et al.
Publicado: (2012)

Targeted Therapy of Ewing's Sarcoma
por: Subbiah, Vivek, et al.
Publicado: (2011)

Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer
por: Fang, Xuefen, et al.
Publicado: (2022)

Identification of novel prognostic biomarkers in the TF-enhancer-target regulatory network in hepatocellular carcinoma and immune infiltration analysis
por: Yan, Jianing, et al.
Publicado: (2023)

A novel prognostic and therapeutic target biomarker based on necroptosis-related gene signature and immune microenvironment infiltration in gastric cancer
por: Xin, Dao, et al.
Publicado: (2022)

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
por: Jain, Arvind, et al.
Publicado: (2017)

Molecular pathogenesis and targeted therapeutics in Ewing sarcoma/primitive neuroectodermal tumours
por: Kelleher, Fergal C, et al.
Publicado: (2012)

EWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma
por: Cidre-Aranaz, Florencia, et al.
Publicado: (2015)

Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma
por: Redini, Françoise, et al.
Publicado: (2015)

Identification of Novel Prognostic Biomarkers Relevant to Immune Infiltration in Lung Adenocarcinoma
por: Xia, Zhi, et al.
Publicado: (2022)

DNA Methylation: An Important Biomarker and Therapeutic Target for Gastric Cancer
por: Zeng, Yunqing, et al.
Publicado: (2022)

Glycolysis- and immune-related novel prognostic biomarkers of Ewing's sarcoma: glucuronic acid epimerase and triosephosphate isomerase 1
por: Jiang, Jie, et al.
Publicado: (2021)

Connexin 43 Is a Potential Prognostic Biomarker for Ewing Sarcoma/Primitive Neuroectodermal Tumor
por: Bui, Marilyn M., et al.
Publicado: (2011)

Cutaneous Ewing Sarcoma and Ewing Sarcoma of the Bone: Distinct Diseases
por: Tavakkoli, Montreh, et al.
Publicado: (2018)

Prognostic analysis of m6A-related genes as potential biomarkers in idiopathic pulmonary fibrosis
por: Wang, Zhiqiang, et al.
Publicado: (2022)

Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis
por: Huang, Runzhi, et al.
Publicado: (2022)

RNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcoma
por: Arora, Shilpi, et al.
Publicado: (2010)

The Receptor Tyrosine Kinase RON and Its Isoforms as Therapeutic Targets in Ewing Sarcoma
por: Berning, Philipp, et al.
Publicado: (2020)

PAK1 and PAK4 as therapeutic targets for Ewing sarcoma: a commentary
por: Parks, Sydney E., et al.
Publicado: (2021)

MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma
por: Zhou, Lei, et al.
Publicado: (2022)

SLC15A4 Serves as a Novel Prognostic Biomarker and Target for Lung Adenocarcinoma
por: Huang, Hui, et al.
Publicado: (2021)

Paired-like homeodomain 2: a novel therapeutic target for atrial fibrillation?
por: Yao, Mengchao, et al.
Publicado: (2014)

Current Therapeutic Approaches in Metastatic and Recurrent Ewing Sarcoma
por: Huang, Michael, et al.
Publicado: (2011)

Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing’s sarcoma
por: Dai, Xing, et al.
Publicado: (2011)

Targeting the p53 Pathway in Ewing Sarcoma
por: Neilsen, Paul M., et al.
Publicado: (2011)

Potential molecular targets for Ewing's sarcoma therapy
por: Jully, Babu, et al.
Publicado: (2012)

Recent advances in targeted therapy for Ewing sarcoma
por: Pishas, Kathleen I., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d2pj8k44v6flhc1dhl3tnisjbi